Side effects of morphine administration in cancer patients

Guillermo Vanegas, Carla Ripamonti, Alberto Sbanotto, Franco De Conno

Research output: Contribution to journalArticle

Abstract

According to the World Health Organization (WHO) guidelines, oral morphine is the first choice drug for treating moderate to severe cancer- related pain. The fear of the side effects caused by this drug and the scarce information about prevention and management of these effects are the main reasons for the underuse of morphine. The aim of this paper is to provide a review of the literature on the side effects most frequently present both in the titration phase and during chronic administration of oral morphine and to describe the appropriate treatment.

Original languageEnglish
Pages (from-to)289-297
Number of pages9
JournalCancer Nursing
Volume21
Issue number4
DOIs
Publication statusPublished - Aug 1998

Fingerprint

Morphine
Neoplasms
Drug-Related Side Effects and Adverse Reactions
Fear
Oral Administration
Guidelines
Pharmaceutical Preparations
Therapeutics
Cancer Pain

Keywords

  • Cancer
  • Morphine
  • Pain
  • Toxicity

ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)

Cite this

Side effects of morphine administration in cancer patients. / Vanegas, Guillermo; Ripamonti, Carla; Sbanotto, Alberto; De Conno, Franco.

In: Cancer Nursing, Vol. 21, No. 4, 08.1998, p. 289-297.

Research output: Contribution to journalArticle

Vanegas, Guillermo ; Ripamonti, Carla ; Sbanotto, Alberto ; De Conno, Franco. / Side effects of morphine administration in cancer patients. In: Cancer Nursing. 1998 ; Vol. 21, No. 4. pp. 289-297.
@article{6a861e29536747749226dc792431c610,
title = "Side effects of morphine administration in cancer patients",
abstract = "According to the World Health Organization (WHO) guidelines, oral morphine is the first choice drug for treating moderate to severe cancer- related pain. The fear of the side effects caused by this drug and the scarce information about prevention and management of these effects are the main reasons for the underuse of morphine. The aim of this paper is to provide a review of the literature on the side effects most frequently present both in the titration phase and during chronic administration of oral morphine and to describe the appropriate treatment.",
keywords = "Cancer, Morphine, Pain, Toxicity",
author = "Guillermo Vanegas and Carla Ripamonti and Alberto Sbanotto and {De Conno}, Franco",
year = "1998",
month = "8",
doi = "10.1097/00002820-199808000-00011",
language = "English",
volume = "21",
pages = "289--297",
journal = "Cancer Nursing",
issn = "0162-220X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Side effects of morphine administration in cancer patients

AU - Vanegas, Guillermo

AU - Ripamonti, Carla

AU - Sbanotto, Alberto

AU - De Conno, Franco

PY - 1998/8

Y1 - 1998/8

N2 - According to the World Health Organization (WHO) guidelines, oral morphine is the first choice drug for treating moderate to severe cancer- related pain. The fear of the side effects caused by this drug and the scarce information about prevention and management of these effects are the main reasons for the underuse of morphine. The aim of this paper is to provide a review of the literature on the side effects most frequently present both in the titration phase and during chronic administration of oral morphine and to describe the appropriate treatment.

AB - According to the World Health Organization (WHO) guidelines, oral morphine is the first choice drug for treating moderate to severe cancer- related pain. The fear of the side effects caused by this drug and the scarce information about prevention and management of these effects are the main reasons for the underuse of morphine. The aim of this paper is to provide a review of the literature on the side effects most frequently present both in the titration phase and during chronic administration of oral morphine and to describe the appropriate treatment.

KW - Cancer

KW - Morphine

KW - Pain

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=0031880351&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031880351&partnerID=8YFLogxK

U2 - 10.1097/00002820-199808000-00011

DO - 10.1097/00002820-199808000-00011

M3 - Article

C2 - 9691512

AN - SCOPUS:0031880351

VL - 21

SP - 289

EP - 297

JO - Cancer Nursing

JF - Cancer Nursing

SN - 0162-220X

IS - 4

ER -